Literature DB >> 19070157

Seroepidemiologic evaluation of anti-toxoplasma antibodies among women in north of Iran.

Mohsen Saeedi1, Gholam Reza Veghari, Abdoljalal Marjani.   

Abstract

This study is a cross sectional and descriptive study. Sample population was the women referred for marriage consultation to Gorgan Marriage Consultation Center in 2004. The prevalence oftoxoplasma antibodies (IgG, IgM) was determined by ELISA method. Blood samples were collected randomly from 300 women referred to the center for consultation. They were transferred to the laboratory for antibodies determination. Gorgan located in north of Iran and south east of Caspian sea. The results showed that the general prevalence to the positive cases based on high titer of IgG was 48.3% and of IgM was 11.7%. There was not any relation between positive cases and age, education, place of residence, job, keeping domestic animals (except cat) vegetable consumption and wash-up, but there was a relation between the positive cases of IgM and keeping cat at home (PV<0.025). More over 51.7% of pregnant women in Gorgan were seronegative and the were prone to acute toxoplasmosis during their pregnancy. The results of this study confirm that the determination of the diagnostic toxoplasmosis is an necessary test during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19070157     DOI: 10.3923/pjbs.2007.2359.2362

Source DB:  PubMed          Journal:  Pak J Biol Sci        ISSN: 1028-8880


  9 in total

1.  Seroprevalence and risk factors for Toxoplasma gondii infection among pregnant women in Northeast Iran.

Authors:  Jalal Babaie; Samira Amiri; Ehsan Mostafavi; Nayereh Hassan; Peyman Lotfi; Ahmad Reza Esmaeili Rastaghi; Majid Golkar
Journal:  Clin Vaccine Immunol       Date:  2013-09-04

2.  Toxoplasma gondii seropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar.

Authors:  Marawan A Abu-Madi; Jerzy M Behnke; Haydee A Dabritz
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

3.  Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study.

Authors:  Sayed Nasser Mostafavi; Behrooz Ataei; Zari Nokhodian; Majid Yaran; Anahita Babak
Journal:  J Res Med Sci       Date:  2011-04       Impact factor: 1.852

4.  Molecular and serological detection of acute and latent toxoplasmosis using real-time PCR and ELISA techniques in blood donors of rafsanjan city, iran, 2013.

Authors:  Nahid Zainodini; Mohammad Zare-Bidaki; Seyyed Hossein Abdollahi; Mohammadreza Afrooz; Naser Ziaali; Mohammad Ebrahimian; Mohammad Kazemi Arababadi
Journal:  Iran J Parasitol       Date:  2014-09       Impact factor: 1.012

5.  Toxoplasma gondii Exposure and the Risk of Schizophrenia.

Authors:  Shahram Khademvatan; Jasem Saki; Niloufar Khajeddin; Maryam Izadi-Mazidi; Reza Beladi; Behnaz Shafiee; Zahra Salehi
Journal:  Jundishapur J Microbiol       Date:  2014-11-01       Impact factor: 0.747

6.  Seroprevalence of Toxoplasma gondii Infections in Pregnant Women in Gorgan City, Golestan Province, Northern Iran-2012.

Authors:  Mitra Sharbatkhori; Yusef Dadi Moghaddam; Abdol Sattar Pagheh; Rasool Mohammadi; Haleh Hedayat Mofidi; Saeedeh Shojaee
Journal:  Iran J Parasitol       Date:  2014 Apr-Jun       Impact factor: 1.012

7.  Seroprevalence of Toxoplasma gondii in Pregnant Women and Bioassay of IgM Positive Cases in Zanjan, Northwest of Iran.

Authors:  F Hajsoleimani; A Ataeian; Aa Nourian; S Mazloomzadeh
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

8.  Toxoplasma gondii infection in women of childbearing age of Isfahan, Iran: A population-based study.

Authors:  Nasser Mostafavi; Behrooz Ataei; Zari Nokhodian; Leila J Monfared; Majid Yaran; Mehdi Ataie; Anahita Babak
Journal:  Adv Biomed Res       Date:  2012-08-28

9.  Molecular Genotyping of Toxoplasma gondii in Human Spontaneous Aborted Fetuses in Shiraz, Southern Iran.

Authors:  Qasem Asgari; Maysam Fekri; Ahmad Monabati; Mohsen Kalantary; Iraj Mohammadpour; Mohammad Hossein Motazedian; Bahador Sarkari
Journal:  Iran J Public Health       Date:  2013-06-01       Impact factor: 1.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.